Oncology & Cancer
England moves to a single-dose HPV vaccine
The HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.
Jun 21, 2023
0
1
Page 6 - News tagged with human papillomaviruses
Health
Cervical cancer screening doubles when under-screened women are mailed at-home testing kits
Researchers at the UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center have found that mailing human papillomavirus (HPV) self-collection tests and offering assistance to book in-clinic ...
May 11, 2023
0
63
Oncology & Cancer
Oral sex is now the leading risk factor for throat cancer, says researcher
Over the past two decades, there has been a rapid increase in throat cancer in the west, to the extent that some have called it an epidemic. This has been due to a large rise in a specific type of throat cancer called oropharyngeal ...
Apr 26, 2023
0
8
Obstetrics & gynaecology
Cervical cancer can be beaten—the key is vaccinating young girls, says gynecological oncologist
In 2020 the World Health Organization introduced a plan to eliminate cervical cancer as a public health threat by 2030. The first step towards this goal is to have 90% of girls fully vaccinated against human papillomavirus ...
Apr 10, 2023
0
2
Oncology & Cancer
Long-term survey reveals worsening death rate for oral cancer in Queensland
A study analyzing 36 years of cancer data has revealed a rising incidence and a worsening death rate for oral cancer in Queensland.
Apr 6, 2023
0
18
Medications
New findings support novel combination treatment for head and neck cancers
Human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) and lung cancer can have disruptive mutations in TP53 and/or CDKN2A tumor suppressor genes, which are associated with poor patient survival.
Apr 5, 2023
0
7
Oncology & Cancer
New drug combination holds unusually positive results for HPV-negative patients with advanced head and neck cancer
A new combination drug treatment has shown promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Mar 28, 2023
0
2
Obstetrics & gynaecology
Mailed human papillomavirus self-sampling kits are cost-effective
Mailing human papillomavirus (HPV) self-sampling kits is an efficient outreach strategy for increasing screening rates among women overdue for screening, according to a study published online March 22 in JAMA Network Open.
Mar 23, 2023
0
10
Oncology & Cancer
Exploring better care for pregnant women with precancerous cervical cancer
Preliminary stages of cervical cancer occur mainly in women between 25 and 35 years of age. The main risk factor for developing cervical cancer is the human papillomavirus (HPV). Surgery is the treatment of choice. However, ...
Mar 15, 2023
0
3
Oncology & Cancer
Australia on track to be the first country to eliminate cervical cancer, but inequities persist
Australia has the potential to be the first country in the world to eliminate cervical cancer as a public health issue.
Mar 7, 2023
0
1
